Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;11(1):11835.
doi: 10.1038/s41598-021-91217-z.

The first competing risk survival nomogram in patients with papillary renal cell carcinoma

Affiliations

The first competing risk survival nomogram in patients with papillary renal cell carcinoma

Xing Su et al. Sci Rep. .

Abstract

There is still a lack of competing risk analysis of patients with papillary renal cell carcinoma (pRCC) following surgery. We performed the cumulative incidence function (CIF) to estimate the absolute risks of cancer-specific mortality (CSM) and other-cause mortality (OCM) of pRCC over time, and constructed a nomogram predicting the probability of 2-, 3- and 5-year CSM based on competing risk regression. A total of 5993 pRCC patients who underwent nephrectomy between 2010 and 2016 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The 2-, 3-, 5-year CSM rates were 3.2%, 4.4% and 6.5%, respectively, and that of OCM were 3.2%, 5.0% and 9.3%, respectively. The estimates of 5-year cumulative mortality were most pronounced among patients aged > 75 years in OCM (17.0%). On multivariable analyses, age, tumor grade, T stage, N stage, and with or without bone, liver and lung metastases were identified as independent predictors of CSM following surgery and were integrated to generate the nomogram. The nomogram achieved a satisfactory discrimination with the AUCt of 0.730 at 5-year, and the calibration curves presented impressive agreements. Taken together, age-related OCM is a significant portion of all-cause mortality in elderly patients and our nomogram can be used for decision-making and patient counselling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The flowchart of patient selection in the SEER database. pRCC papillary renal cell carcinoma.
Figure 2
Figure 2
Cumulative incidences curves of cancer and noncancer death in the total cohort. The figure was performed using R software (version 4.0.3, R Core Team 2020, https://www.r-project.org/).
Figure 3
Figure 3
Cumulative incidences curves of CSM according to age (A), tumor grade (B), T stage (C) and N stage (D). The differences between groups were assessed by Gray’s test. CSM cancer-specific mortality. The figure was performed using R software (version 4.0.3, R Core Team 2020, https://www.r-project.org/).
Figure 4
Figure 4
Cumulative incidences curves of OCM according to age (A) and sex (B). The differences between groups were assessed by Gray’s test. OCM other-cause mortality. The figure was performed using R software (version 4.0.3, R Core Team 2020, https://www.r-project.org/).
Figure 5
Figure 5
Competing risk nomogram predicting 2-, 3- and 5-year probabilities of CSM. CSM cancer-specific mortality. The figure was performed using R software (version 4.0.3, R Core Team 2020, https://www.r-project.org/).
Figure 6
Figure 6
The calibration curves of the predicted probabilities and observed CSM rates. The 45-degree diagonal represents perfect agreements between the nomogram-predicted probabilities (X-axes) and the observed CSM rates (Y-axes). CSM cancer-specific mortality. The figure was performed using R software (version 4.0.3, R Core Team 2020, https://www.r-project.org/).

Similar articles

Cited by

References

    1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Srigley JR, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am. J. Surg. Pathol. 2013;37:1469–1489. doi: 10.1097/PAS.0b013e318299f2d1. - DOI - PubMed
    1. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: Renal, penile, and testicular tumours. Eur. Urol. 2016;70:93–105. doi: 10.1016/j.eururo.2016.02.029. - DOI - PubMed
    1. Linehan WM, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 2016;374:135–145. doi: 10.1056/NEJMoa1505917. - DOI - PMC - PubMed
    1. Zisman A, et al. Mathematical model to predict individual survival for patients with renal cell carcinoma. J. Clin. Oncol. 2002;20:1368–1374. doi: 10.1200/jco.2002.20.5.1368. - DOI - PubMed

MeSH terms